ZA979726B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number: ZA979726B
Authority: ZA; South Africa
Prior art keywords: pharmaceutical compositions; pharmaceutical; compositions
Prior art date: 1996-10-31

Application number

ZA979726A

Other languages

English (en)

Inventor

Gary Wayne Goodson

Katherine Jeanette Ford

Allen Wayne Wood

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-31

Filing date

1997-10-29

Publication date

1999-04-29

1997-10-29 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1999-04-29 Publication of ZA979726B publication Critical patent/ZA979726B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Immunology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)

ZA979726A 1996-10-31 1997-10-29 Pharmaceutical compositions ZA979726B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9622681.6A GB9622681D0 (en)	1996-10-31	1996-10-31	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
ZA979726B true ZA979726B (en)	1999-04-29

Family

ID=10802224

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA979726A ZA979726B (en)	1996-10-31	1997-10-29	Pharmaceutical compositions

Country Status (43)

Country	Link
EP (1)	EP0941100B1 (is)
JP (1)	JP2001502718A (is)
KR (1)	KR100551652B1 (is)
AP (1)	AP1067A (is)
AR (1)	AR009135A1 (is)
AT (1)	ATE241364T1 (is)
AU (1)	AU736607B2 (is)
BG (1)	BG64541B1 (is)
BR (1)	BR9712614A (is)
CA (1)	CA2270174A1 (is)
CO (1)	CO4930269A1 (is)
CY (1)	CY2485B1 (is)
CZ (1)	CZ296080B6 (is)
DE (1)	DE69722433T2 (is)
DK (1)	DK0941100T3 (is)
EA (1)	EA002437B1 (is)
EE (1)	EE03806B1 (is)
ES (1)	ES2200204T3 (is)
GB (1)	GB9622681D0 (is)
GE (1)	GEP20022735B (is)
GT (1)	GT199700116A (is)
HR (1)	HRP970569B1 (is)
HU (1)	HU224969B1 (is)
ID (1)	ID18698A (is)
IL (1)	IL129422A0 (is)
IS (1)	IS5024A (is)
MY (1)	MY119513A (is)
NO (1)	NO317163B1 (is)
NZ (1)	NZ335153A (is)
OA (1)	OA11038A (is)
PA (1)	PA8441101A1 (is)
PE (1)	PE10099A1 (is)
PL (1)	PL190349B1 (is)
PT (1)	PT941100E (is)
SI (1)	SI0941100T1 (is)
SK (1)	SK284286B6 (is)
SV (1)	SV1997000090A (is)
TR (1)	TR199900950T2 (is)
UA (1)	UA64725C2 (is)
UY (1)	UY24766A1 (is)
WO (1)	WO1998018477A2 (is)
YU (1)	YU19999A (is)
ZA (1)	ZA979726B (is)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9622681D0 (en) *	1996-10-31	1997-01-08	Glaxo Group Ltd	Pharmaceutical compositions
GB9809213D0 (en) *	1998-04-29	1998-07-01	Glaxo Group Ltd	Pharmaceutical compositions
US7074417B2 (en) *	2000-10-13	2006-07-11	Advancis Pharmaceutical Corporation	Multiple-delayed release anti-viral product, use and formulation thereof
EP1501521B1 (en) *	2002-04-23	2007-05-02	Lupin Limited	Long acting compositions comprising zidovudine and/or lamivudine
CA2505130C (en) *	2002-11-08	2009-10-06	Glaxo Group Limited	Pharmaceutical compositions
WO2004064845A1 (en)	2003-01-14	2004-08-05	Gilead Sciences, Inc.	Compositions and methods for combination antiviral therapy
AR045841A1 (es) *	2004-09-28	2005-11-16	Richmond Sa Com Ind Y Financie	Una composicion farmaceutica solida que comprende al tiazolil metil ester del acido [5s-(5r, 8r, 10r,11r)] -10- hidroxi-2- metil-5-(1-metiletil)-1-[2-(1-metiletil)-4-tiazolil]-3,6-dioxo-8,11-bis(fenilmetil)-2,4,7,12- tetraazatridecan-13-oico y un procedimiento para prepararla.
WO2011156594A2 (en)	2010-06-09	2011-12-15	Vaccine Technologies, Incorporated	Therapeutic immunization in hiv infected subjects receiving stable antiretroviral treatment
BR112014021927A2 (pt)	2012-03-05	2019-09-24	Cipla Ltd	composição farmacêutica antirretroviral, processo para preparar uma composição farmacêutica antirretroviral, método para o tratamento ou profilaxia de doenças causadas por retrovírus, e, uso de lamivudina, festinavir e nevirapina
EP2958563A2 (en) *	2013-02-20	2015-12-30	AbbVie Inc.	Tablet dosage form comprising ritonavir and lopinavir

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4950652A (en) *	1987-03-23	1990-08-21	Hem Research, Inc.	dsRNAs for combination therapy in the treatment of viral diseases
EP0513917B2 (en) *	1991-05-16	2001-03-07	Glaxo Group Limited	Antiviral combinations containing nucleoside analogs
GB9110624D0 (en) *	1991-05-16	1991-07-03	Glaxo Group Ltd	Combinations
GB9622681D0 (en) *	1996-10-31	1997-01-08	Glaxo Group Ltd	Pharmaceutical compositions

1996
- 1996-10-31 GB GBGB9622681.6A patent/GB9622681D0/en active Pending
1997
- 1997-10-24 HR HR970569A patent/HRP970569B1/xx not_active IP Right Cessation
- 1997-10-28 SV SV1997000090A patent/SV1997000090A/es not_active Application Discontinuation
- 1997-10-28 CO CO97063174A patent/CO4930269A1/es unknown
- 1997-10-28 MY MYPI97005103A patent/MY119513A/en unknown
- 1997-10-29 ES ES97950036T patent/ES2200204T3/es not_active Expired - Lifetime
- 1997-10-29 KR KR1019997003757A patent/KR100551652B1/ko not_active Expired - Fee Related
- 1997-10-29 CA CA002270174A patent/CA2270174A1/en not_active Abandoned
- 1997-10-29 TR TR1999/00950T patent/TR199900950T2/xx unknown
- 1997-10-29 PL PL97333143A patent/PL190349B1/pl unknown
- 1997-10-29 BR BR9712614-4A patent/BR9712614A/pt not_active IP Right Cessation
- 1997-10-29 GE GEAP19974781A patent/GEP20022735B/en unknown
- 1997-10-29 CZ CZ0155799A patent/CZ296080B6/cs not_active IP Right Cessation
- 1997-10-29 EE EEP199900175A patent/EE03806B1/xx not_active IP Right Cessation
- 1997-10-29 PT PT97950036T patent/PT941100E/pt unknown
- 1997-10-29 WO PCT/EP1997/005953 patent/WO1998018477A2/en not_active Ceased
- 1997-10-29 UA UA99042239A patent/UA64725C2/uk unknown
- 1997-10-29 JP JP10520045A patent/JP2001502718A/ja active Pending
- 1997-10-29 NZ NZ335153A patent/NZ335153A/en unknown
- 1997-10-29 DE DE69722433T patent/DE69722433T2/de not_active Expired - Lifetime
- 1997-10-29 IL IL12942297A patent/IL129422A0/xx not_active IP Right Cessation
- 1997-10-29 HU HU0000344A patent/HU224969B1/hu not_active IP Right Cessation
- 1997-10-29 AT AT97950036T patent/ATE241364T1/de active
- 1997-10-29 EA EA199900345A patent/EA002437B1/ru not_active IP Right Cessation
- 1997-10-29 ZA ZA979726A patent/ZA979726B/xx unknown
- 1997-10-29 AR ARP970105027A patent/AR009135A1/es unknown
- 1997-10-29 DK DK97950036T patent/DK0941100T3/da active
- 1997-10-29 SI SI9730570T patent/SI0941100T1/xx unknown
- 1997-10-29 YU YU19999A patent/YU19999A/sh unknown
- 1997-10-29 EP EP97950036A patent/EP0941100B1/en not_active Expired - Lifetime
- 1997-10-29 SK SK575-99A patent/SK284286B6/sk unknown
- 1997-10-29 AP APAP/P/1999/001519A patent/AP1067A/en active
- 1997-10-29 PE PE1997000965A patent/PE10099A1/es not_active Application Discontinuation
- 1997-10-29 AU AU53142/98A patent/AU736607B2/en not_active Ceased
- 1997-10-29 GT GT199700116A patent/GT199700116A/es unknown
- 1997-10-30 PA PA19978441101A patent/PA8441101A1/es unknown
- 1997-10-30 UY UY24766A patent/UY24766A1/es not_active IP Right Cessation
- 1997-10-30 ID IDP973554A patent/ID18698A/id unknown
1999
- 1999-04-09 IS IS5024A patent/IS5024A/is unknown
- 1999-04-23 OA OA9900088A patent/OA11038A/en unknown
- 1999-04-29 NO NO19992091A patent/NO317163B1/no unknown
- 1999-05-26 BG BG103435A patent/BG64541B1/bg unknown
2004
- 2004-11-26 CY CY0400085A patent/CY2485B1/xx unknown

Also Published As

Publication number	Publication date
AU5314298A (en)	1998-05-22
NO992091L (no)	1999-06-29
PA8441101A1 (es)	2000-05-24
ES2200204T3 (es)	2004-03-01
NO992091D0 (no)	1999-04-29
SK57599A3 (en)	2000-06-12
AU736607B2 (en)	2001-08-02
GEP20022735B (en)	2002-07-25
GT199700116A (es)	1999-04-22
AP9901519A0 (en)	1999-06-30
PT941100E (pt)	2003-10-31
PL190349B1 (pl)	2005-11-30
KR20000052893A (ko)	2000-08-25
CY2485B1 (en)	2005-06-03
SK284286B6 (sk)	2005-01-03
AP1067A (en)	2002-05-01
HU224969B1 (en)	2006-04-28
CA2270174A1 (en)	1998-05-07
TR199900950T2 (xx)	1999-07-21
NZ335153A (en)	2001-04-27
HUP0000344A2 (hu)	2001-05-28
DE69722433T2 (de)	2004-04-08
EE9900175A (et)	1999-12-15
YU19999A (sh)	2000-10-30
BR9712614A (pt)	1999-10-26
HK1020880A1 (en)	2000-05-26
IS5024A (is)	1999-04-09
HUP0000344A3 (en)	2002-04-29
SV1997000090A (es)	1998-10-07
ATE241364T1 (de)	2003-06-15
BG64541B1 (bg)	2005-07-29
WO1998018477A3 (en)	1998-06-18
DE69722433D1 (de)	2003-07-03
GB9622681D0 (en)	1997-01-08
BG103435A (en)	2000-04-28
EA002437B1 (ru)	2002-04-25
OA11038A (en)	2002-02-06
EP0941100A2 (en)	1999-09-15
NO317163B1 (no)	2004-08-30
SI0941100T1 (en)	2003-12-31
UA64725C2 (uk)	2004-03-15
CO4930269A1 (es)	2000-06-27
WO1998018477A2 (en)	1998-05-07
DK0941100T3 (da)	2003-09-01
ID18698A (id)	1998-04-30
UY24766A1 (es)	2000-12-29
JP2001502718A (ja)	2001-02-27
MY119513A (en)	2005-06-30
KR100551652B1 (ko)	2006-02-13
IL129422A0 (en)	2000-02-17
HRP970569B1 (en)	2004-10-31
EE03806B1 (et)	2002-08-15
AR009135A1 (es)	2000-03-08
CZ296080B6 (cs)	2006-01-11
EA199900345A1 (ru)	2000-02-28
PL333143A1 (en)	1999-11-22
CZ155799A3 (cs)	1999-10-13
HRP970569A2 (en)	1998-08-31
EP0941100B1 (en)	2003-05-28
PE10099A1 (es)	1999-03-02

Publication	Publication Date	Title
EG24118A (en)	2008-07-06	Pharmaceutical compositions
GB9727053D0 (en)	1998-02-18	Pharmaceutical compositions
GB9616672D0 (en)	1996-09-25	Pharmaceutical compositions
ZA9710006B (en)	1999-06-05	Novel pharmaceutical compositions
GB9610359D0 (en)	1996-07-24	Pharmaceutical compositions
AP9901657A0 (en)	1999-09-30	Pharmaceutical compositions
IL131995A0 (en)	2001-03-19	Gastric-retained pharmaceutical compositions
GB9723985D0 (en)	1998-01-14	Pharmaceutical compositions
ZA954469B (en)	1996-01-24	Pharmaceutical compositions
ZA979726B (en)	1999-04-29	Pharmaceutical compositions
GB9726735D0 (en)	1998-02-18	Pharmaceutical compositions
GB9606429D0 (en)	1996-06-05	Pharmaceutical compositions
GB9613457D0 (en)	1996-08-28	Pharmaceutical compositions
GB9623962D0 (en)	1997-01-08	Pharmaceutical composition
HU9700632D0 (en)	1997-05-28	Pharmaceutical compositions
GB9618376D0 (en)	1996-10-16	Pharmaceutical compositions
GB9610136D0 (en)	1996-07-24	Pharmaceutical compositions
GB9400047D0 (en)	1994-03-02	Pharmaceutical compositions
HUP0003528A3 (en)	2001-07-30	Pharmaceutical compositions containing dihydropolyprenols
ZA982117B (en)	1998-09-14	Pharmaceutical compositions
GB9718270D0 (en)	1997-11-05	Pharmaceutical compositions
GB9603942D0 (en)	1996-04-24	Pharmaceutical compositions
GB9606586D0 (en)	1996-06-05	Pharmaceutical compositions
SI0941095T1 (en)	2004-12-31	Improved pharmaceutical compositions
GB9623225D0 (en)	1997-01-08	Novel pharmaceutical compositions